Statistical analysis
death
DISEASE PROGRESSION
The efficacy and safety were analyzed in all patients who received at least one dose of the study treatment. Categorical and continuous variables were compared using Fisher’s exact test and the Wilcoxon rank–sum test, respectively. PFS and OS were defined as the time from treatment initiation until evidence of disease progression or death from any cause. Survival was plotted using Kaplan–Meier curves and compared using the log–rank test. The censoring date is April 25, 2023. Statistical analyses were performed using SAS 9.4 and GraphPad Prism version 6 (GraphPad Software).